Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Federal AI & Digital Transformation Summit
The 2027 AI Summit brings together federal and industry technology leaders to explore how agencies are moving AI from experimentation to enterprise-wide adoption
Washington, D.C. -
Agencies Need Real-Time Visibility to Keep Pace With AI Risks
Officials say static inventories cannot keep pace with AI and are calling for continuous monitoring and stronger risk management.
3m read -
GSA Reveals PQC Priorities to Secure Identity Management
Following a White House executive order, GSA's PQC priorities tackle digital identity and building access systems from quantum threats.
2m read -
What Battery Recycling Could Tell Us About AI's Role in Experimentation
A Genesis Mission project tests how AI agents can reduce physical experiments and accelerate critical mineral recovery from used batteries.
4m read
